erythromycin lactobionate

Erythromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by targeting the 50S ribosomal subunit, blocking the progression of nascent polypeptide chains.[1] It is effective against a host of bacterial genera, including Streptococcus, Staphylococcus, and Haemophilus (MIC90s range from 0.015-2.0 mg/l).[2] Erythromycin is known to potently inhibit the cytochrome P450 isoform CYP3A4, which can affect the metabolism of numerous clinically relevant medications.[3],[4] Erythromycin lactobionate is a soluble salt of erythromycin that is typically used for intraperitoneal or intravenous injections.[5],[6]

Erythromycin (E-Mycin) 是由放线菌产生的大环内酯类抗生素。它结合细菌的 50S 核糖体亚基，通过阻断转肽和易位反应来抑制 RNA 依赖性蛋白的合成。

Erythromycin-13C-d3 是一种 13C- 和氘代标记的 Erythromycin，可用于研究 Erythromycin 在体内的代谢流程。

Erythromycin hydrochloride is an inhibitor of protein translation and mammalian mRNA splicing. It inhibits growth of gram negative and gram positiove bacteria.

Erythromycin estolate是一种半合成的红霉素衍生物，具有良好的口服吸收性和生物利用度耐酸性。作为大环内酯类抗生素，依托红霉素通过抑制细菌蛋白质合成发挥抗菌作用，主要用于治疗由敏感细菌引起的呼吸道、皮肤和软组织感染研究。Erythromycin estolate可能引起肝损伤，包括轻度的胆汁淤积性肝炎、黄疸和胆管缺乏。

Erythromycin Gluceptate is an inhibitor of protein translation and mammalian mRNA splicing. It inhibits growth of gram negative and gram positiove bacteria.